HALLEY Venture Partners

Halley Venture Partners, founded in 2017 and based in San Francisco, is a venture capital firm that specializes in investing in the legal cannabis and hemp industries. The firm, led by Managing Director Steve Schuman, focuses on early-stage investments, particularly in technology and medical companies that are driving innovation within the cannabis sector. With a background in public and private equity, Schuman and his team bring significant expertise to their portfolio, which includes companies like Willow Industries, Front Range Biosciences, and PathogenDx. Halley Venture Partners typically invests in Seed, Series A, and Series B rounds, supporting startups that are developing scalable solutions and transformative technologies in the cannabis space. The firm is dedicated to building highly scalable businesses, leveraging deep industry knowledge and a hands-on approach to guide companies through the complexities of the rapidly evolving cannabis market. The team at Halley Venture Partners includes experienced professionals like Aaron Taffet, who brings a strong background in private equity and cannabis operations, and advisors such as Ephraim Lindenbaum and Lauren Fraser, who contribute valuable insights from their extensive experience in venture capital and cannabis distributio.